Avanir Pharmaceuticals, Inc.
is a biopharmaceutical company focused on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders.

Press Releases

Football Hall-of-Famer Barry Sanders Tackles Pseudobulbar Affect; A Little-known But Widespread Condition Caused by Brain Injury
Jan 20, 2015
Through Laughter and Tears Comes First-Ever Documentary about Life with PseudoBulbar Affect (PBA)
Dec 9, 2014
Avanir Pharmaceuticals Cancels Previously Scheduled Earnings Call
Dec 5, 2014